Vascular Access Device Market Outlook:
Vascular Access Device Market size was over USD 6.82 billion in 2025 and is projected to reach USD 12.45 billion by 2035, witnessing around 6.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of vascular access device is evaluated at USD 7.2 billion.
The growth of the market can be attributed to the growing burden of diseases worldwide as well as the rising number of hospital admissions together with the augmenting percentage of surgeries that require repeated and long-term access to the bloodstream for frequent or regular administration of drugs. For instance, it was observed that a staggering 310 million major surgeries are performed worldwide annually.
In addition to these, factors that are believed to fuel the vascular access device market growth of irritable bowel syndrome drugs include the increasing number of approvals, along with the rise in clinical trials on the available technologies confirming the safety and cost-efficiency of vascular access devices. For instance, in May 2022, Teleflex Incorporated, a leading global provider of medical technologies, announced the receipt of Health Canada approval for the MANTA Vascular Closure Device, which was the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure. Additionally, the growing number of collaborations, acquisitions, and soaring investments is predicted to present the potential for market expansion over the projected period.
